Who founded Empatica?

Empatica was founded by Rosalind Picard, Matteo Lai, Simone Tognetti in 2013.

Who are Empatica's investors?

Empatica's investors include Black Opal Ventures, CDP Venture Capital, RA Capital, Sanofi Ventures.

How much funding has Empatica raised?

Empatica has disclosed $26.9M raised across 2 rounds.

Where is Empatica headquartered?

Empatica is headquartered in Cambridge, US.

Empatica

Cambridge, US · Founded 2013 · Delaware corporation · 135 employees on LinkedIn · 4 known investors

Find your way into Empatica

1,822 people in our graph share verified history with the Empatica team — schools, employers, funds. One of them is your warm intro.

Wesley Chanunlockedknows Rosalind Picard · together at Massachusetts Institute of Technology (overlapped)

×8knows the team · via Massachusetts Institute of Technology

knows the team · via Akamai Technologies

knows the team · via Politecnico di Milano

knows the team · via Politecnico di Torino

Empatica offers an FDA-cleared health monitoring platform combining medical wearables and digital biomarkers to collect continuous, clinical-quality health data from daily life. It serves researchers, clinicians, and pharmaceutical companies for clinical trials and remote patient monitoring across therapeutic areas including neurology and Parkinson's disease.

AI & Machine Learning Digital Health Healthtech Medical Devices

Founders & leadership

Empatica was founded in 2013 by Rosalind Picard, Matteo Lai, and Simone Tognetti.

Rosalind Picard inCo-founder, Chief ScientistRosalind Picard is Founder and Director of the Affective Computing Group at MIT Media Lab. She previously worked at AT&T Bell Labs designing computer chips and algorithms, co-founded Empatica and Affectiva, and has expertise in machine learning, pattern analysis, and wearable technology development.

Matteo Lai inCo-founder and CEOMatteo Lai is co-founder and CEO of Empatica, an MIT spin-off based in Cambridge and Milan that develops medical wearables and AI systems for continuous health monitoring. He has built the company to FDA clearance for use in neurology and works with clinicians, researchers, and patients on physiological monitoring through wearable sensors.

Simone Tognetti inCTO & co-founderSimone Tognetti has a background in physiology research and an early interest in biomedical measurement technology. At Empatica, he oversees research and development for hardware and software, production, and regulatory affairs.

Len Picard inVP Engineering2014–2014Len Picard holds a Ph.D. in Electrical Engineering and Computer Science from MIT and a bachelor's degree from MIT's Sloan School of Management. He brings extensive experience in engineering management across hardware and software products, including medical devices and embedded systems, with background in product development, vision and image processing, and leading geographically distributed engineering teams.

Mario ScuderiNamed on SEC filing

Investors · 4

Black Opal VenturesNew York

CDP Venture CapitalRome

RA CapitalBoston

Sanofi VenturesCambridge · $5M

Reported raises · per SEC filings

Form D private placements

$26.9M disclosed across 2 rounds · 2014–2022

▶$25.9MraisedAug 2022 · 8 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Rosalind PicardDirector
Matteo LaiExecutive Officer, Director
Mario ScuderiDirector
Simone TognettiDirector

Offering amount: $33.9M
Amount sold: $25.9M
First sale: Jul 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1MraisedApr 2014 · 2 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Rosalind PicardExecutive Officer, Director
Len PicardExecutive Officer, Director

Offering amount: $2M
Amount sold: $1M
Minimum investment: $1M
First sale: Apr 2014
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Epiwatch132 shared keywordsEpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers. The app is designed for people with epilepsy in the United States to help reduce the risk of sudden unexpected death in epilepsy (SUDEP) and enable faster intervention.

Companies competing with Empatica for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Trysignalbasetrysignalbase.com · Oct 2024

Empatica receives new FDA clearance for its Health Monitoring Platform and announces Series B financingprnewswire.com · Nov 2022

Empatica Raises Series B Financing - FinSMEsfinsmes.com · Nov 2022

Frequently asked questions

What does Empatica do?: Empatica offers an FDA-cleared health monitoring platform combining medical wearables and digital biomarkers to collect continuous, clinical-quality health data from daily life. It serves researchers, clinicians, and pharmaceutical companies for clinical trials and remote patient monitoring across therapeutic areas including neurology and Parkinson's disease.
Who founded Empatica?: Empatica was founded by Rosalind Picard, Matteo Lai, Simone Tognetti in 2013.
Who are Empatica's investors?: Empatica's investors include Black Opal Ventures, CDP Venture Capital, RA Capital, Sanofi Ventures.
How much funding has Empatica raised?: Empatica has disclosed $26.9M raised across 2 rounds.
Where is Empatica headquartered?: Empatica is headquartered in Cambridge, US.